Medicure (MCUJF) Total Non-Current Liabilities (2009 - 2026)

Medicure's (MCUJF) quarterly Total Non-Current Liabilities came in at $253763.6 in Q1 2026, down 18.36% year-on-year from $310824.7 in Q1 2025, and down 17.12% quarter-over-quarter from $306195.8 in Q4 2025.

Medicure (MCUJF) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Medicure's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $253763.6 for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 18.36% year-over-year to $253763.6 in Q1 2026; TTM through Mar 2026 was $253763.6, a 18.36% decrease from a year earlier, with the FY2025 full-year figure at $305613.1, down 17.31% from the prior year.
  • Total Non-Current Liabilities declined to $253763.6 in Q1 2026 per MCUJF's latest filing, from $306195.8 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 million in Q1 2022 and bottomed at $136723.3 in Q2 2024.
  • The 5-year median for Total Non-Current Liabilities is $339035.0 (2024), against an average of $433540.6.
  • Across the five-year window, Total Non-Current Liabilities tumbled 79.85% in 2023 and jumped 222.52% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $370561.6 in 2022, then slumped by 54.61% to $168208.6 in 2023, then jumped by 115.34% to $362219.7 in 2024, then slipped by 15.47% to $306195.8 in 2025, then retreated by 17.12% to $253763.6 in 2026.
  • Per Business Quant, the three latest MCUJF Total Non-Current Liabilities figures stand at $253763.6 (Q1 2026), $306195.8 (Q4 2025), and $377850.2 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Medicure 8.77 Mn 7.64 Mn 2.57 Mn 253,763.58

Historic Data

Download Data
DateValue
Mar 31, 2026 253,763.58
Dec 31, 2025 306,195.84
Sep 30, 2025 377,850.20
Jun 30, 2025 440,966.34
Mar 31, 2025 310,824.75
Dec 31, 2024 362,219.67
Sep 30, 2024 407,577.70
Jun 30, 2024 136,723.28
Mar 31, 2024 155,843.77
Dec 31, 2023 168,208.64
Sep 30, 2023 205,130.88
Mar 31, 2023 315,850.35
Dec 31, 2022 370,561.58
Sep 30, 2022 1.02 Mn
Jun 30, 2022 1.03 Mn
Mar 31, 2022 1.08 Mn
Dec 31, 2021 1.18 Mn
Sep 30, 2021 1.81 Mn
Jun 30, 2021 1.91 Mn
Mar 31, 2021 1.96 Mn